Cargando…
Is treatment with interferon-α effective in all patients with metastatic renal carcinoma? A new approach to the investigation of interactions
The first analysis of the MRC RE01 trial in metastatic renal carcinoma identified a 28% reduction in the hazard of death for patients treated with interferon-α compared with medroxyprogesterone acetate (MPA). No subgroup was identified in which treatment with interferon-α was more or less effective...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2004
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410187/ https://www.ncbi.nlm.nih.gov/pubmed/14970855 http://dx.doi.org/10.1038/sj.bjc.6601622 |